The NY Times reports that a federal judge on Monday struck down patents on two genes linked to breast and ovarian cancer. The decision, if upheld, could throw into doubt the patents covering thousands of human genes and reshape the law of intellectual property.
U.S. Judge Invalidates Human Gene Patent
March 30, 2010
Share this post
2 Comments

Law Bytes
Episode 283: Sabine Witting on Why the French Constitutional Council Struck Down France's Under-15 Social Media Ban
byMichael Geist

November 16, 2026
Michael Geist
November 9, 2026
Michael Geist
November 2, 2026
Michael Geist
October 26, 2026
Michael Geist
October 19, 2026
Michael Geist
Search Results placeholder
Michael Geist on Substack
Recent Posts
What Happened to Competition? Why Sovereignty Is the Wrong Answer to Quebecor’s Bid for Telus
The Law Bytes Podcast, Episode 283: Sabine Witting on Why the French Constitutional Council Struck Down France’s Under-15 Social Media Ban
Back-of-the-Napkin Cultural Policy: The Government’s $600 Million Streaming Plan Copies the CRTC Decision It Killed at More Than Double the Cost
The Law Bytes Podcast, Episode 282: Udbhav Tiwari on Why Signal May Exit Canada Over Bill C-22’s Encryption and Metadata Retention Rules
From Making Web Giants Pay to Paying Media Giants: Budget 2026 Replaces the Government’s Internet Platform Strategy With $1.5 Billion in Taxpayer Dollars for Culture and News

“Myriad Genetics, the company that holds the patents with the University of Utah Research Foundation, asked the court to dismiss the case, claiming that the work of isolating the DNA from the body transforms it and makes it patentable. ”
So, they claim they aren’t actually patenting the two genes, they are patenting transformed version of the genes? To me this would invalidate the work of the human genome project, as they cataloged not the human genome but some variation thereof… Or am I understanding the claim incorrectly?
They’re claiming that isolated DNA is “transformed”, so the not-found-in-nature requirement of a patent doesn’t apply to the genes.